GOLDBERG ARTHUR S 4
4 · HI TECH PHARMACAL CO INC · Filed Jan 20, 2004
Insider Transaction Report
Form 4
GOLDBERG ARTHUR S
VP-Finance, CFO
Transactions
- Exercise/Conversion
Common Stock
2004-01-16$2.67/sh+374$997→ 374 total - Exercise/Conversion
Common Stock
2004-01-16$5.76/sh+3,626$20,886→ 4,000 total - Exercise/Conversion
Stock Option (Right to Buy)
2004-01-15$2.67/sh−2,438$6,502→ 3,187 totalExercise: $2.67From: 2001-06-01Exp: 2010-05-31→ Common Stock (2,438 underlying) - Exercise/Conversion
Stock Option (Right to Buy)
2004-01-16$5.76/sh−3,626$20,886→ 7,624 totalExercise: $5.76From: 2002-11-15Exp: 2011-11-14→ Common Stock (3,626 underlying) - Exercise/Conversion
Common Stock
2004-01-15$2.67/sh+2,438$6,502→ 2,438 total - Exercise/Conversion
Stock Option (Right to Buy)
2004-01-16$2.67/sh−374$997→ 2,813 totalExercise: $2.67From: 2001-06-01Exp: 2010-05-31→ Common Stock (374 underlying) - Sale
Common Stock
2004-01-16$26.80/sh−2,000$53,600→ 2,000 total - Sale
Common Stock
2004-01-15$26.60/sh−2,438$64,851→ 0 total
Footnotes (2)
- [F1]Options become exercisable in 4 annual installments beginning on the first anniversary of the grant date.
- [F2]Other than the options listed in Column 9, Mr. Goldberg is also the owner of options to purchase an aggregate of 25,000 shares of Hi-Tech Pharmacal Co., Inc.'s common stock. Such options are exercisable at various prices and became or will become exercisable on various exercise dates.